This page summarizes information about the organizations (Orgs) that have contributed to the clinical-stage research and development of both innovator medicines as well as their generic equivalents. Please note the lead sponsor for a trial is the organization with responsibility for conducting the trial and reporting the information to ClinicalTrials.gov. Additional information on this page includes fundamental backgrounds of the organizations, the active pharmaceuticals under investigation, clinical trials, diseases investigated as well as mechanisms and targets explored. We identify the different types of sponsoring organizations regardless of whether these arise from the public (defined as academia, non-profits and foundations), the private sector (both public and private companies) and government.
Trial Lead Sponsors
Top 5 (by most trials)
National Cancer Institute (NCI) (3507) Pfizer (3130) Novartis (2998) GlaxoSmithKline (2970) Harvard University (2496)Received FDA Approval
Top 5 (by most approved APIs)
Mylan (569) Teva (526) Aurobindo Pharma (384) Novartis (379) Sun Pharmaceuticals (378)Received NME Approval
Top 5 (by most approved NMEs)
Merck (96) Novartis (79) Pfizer (77) Roche (73) Eli Lilly (72)Private Sector Sponsors
Top 5 (by most trials)
Pfizer (4287) Novartis (4046) GlaxoSmithKline (3993) Merck (3661) AstraZeneca (3146)org_id | earliest_year | Sponsor | Lead Sponsor Years | Lead Sponsor Trials | Total Trials | Org Type |
---|
NME Approval Sponsors
Top 5 (by most approved NMEs)
Merck (96) Novartis (79) Pfizer (77) Roche (73) Eli Lilly (72)Secondary NDA Sponsors
Top 5 (by most approved APIs)
Novartis (155) Pfizer (123) GlaxoSmithKline (120) Sanofi-Aventis (118) AbbVie (103)Generics Approval Sponsors
Top 5 (by most approved APIs)
Mylan (541) Teva (504) Aurobindo Pharma (382) Sun Pharmaceuticals (369) Hikma (340)org_id | earliest_year | Sponsor | NME Years | NME Approvals | Secondary NDAs | Generics Approvals | Org Type |
---|